Method of treating airway diseases with beta-adrenergic inverse agonists
作者： Richard A. Bond
DOI:
关键词:
摘要: The use of β-adrenergic inverse agonists provides a new and highly efficient way treating number pulmonary airway diseases, including asthma, emphysema, chronic obstructive diseases. In general, such method comprises administering therapeutically effective amount agonist to the subject treat disease. Particularly preferred include nadolol carvedilol.
google.ca 参考文章(64)
Alec D. Keith, Sustained release propranolol system ,(1982)
Allan I. Basebaum, Jon D. Levine, Use of beta2 antagonists in the treatment of inflammatory diseases, in particular, rheumatoid arthritis ,(1988)
Richard G. Lanzara, Method for determining drug compositions to prevent desensitization of cellular receptors ,(1995)
Katherine A. Fitzgerald, The cytokine factsbook Academic Press. ,(2001)
Roger A. Moraga Martinez, Gunnar Thor Sigurdsson, Nucleic acids encoding olfactory receptors ,(2002)
Ke-Fei Shen, Stanley M. Crain, Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside ,(2002)
Ke-fei Shen, Stanley M. Crain, Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists ,(1993)
Richard G. Lanzara, Drug composition to prevent desensitization of cellular receptors ,(1993)
Samuel Broder, Tahir Ahmed, Methods and compositions for treatment of asthma Official Gazette of the United States Patent and Trademark Office Patents. ,(1998)
Richard G. Lanzara, Compositions to enhance the efficacy and safety of bio-pharmaceutical drugs ,(2001)